Server Updates We will be completing server updates between 3:00 - 6:00 AM Eastern on Wednesday, March 25. Thanks for your patience while we improve SDN!
FA 2013 pg 360: under Hereditary thrombosis syndrome leading to hypercoagulability. In protein C or S deficiency, it says "increased risk of thrombotic skin necrosis with hemorrhage following administration of warfarin"
FA 2013 pg 360: under Hereditary thrombosis syndrome leading to hypercoagulability. In protein C or S deficiency, it says "increased risk of thrombotic skin necrosis with hemorrhage following administration of warfarin"
Protein C is an anticoagulant with a shorter half-life than some of the coagulation factors > administer warfarin > deplete protein C first > temporary hypercoagulable state > blood clot to skin's blood supply > necrosis.
FA 2013 pg 360: under Hereditary thrombosis syndrome leading to hypercoagulability. In protein C or S deficiency, it says "increased risk of thrombotic skin necrosis with hemorrhage following administration of warfarin"
Because Protein C and S are both vitamin K dependent (anti-clotting) factors. And Warfarin affects them stronger at first. (Protein C has the shortest half life of all the VitaminK dependent factors)
In patients with protein C and S deficiency, there is an increased risk of skin necrosis because of the above.
Interestingly, because PT measurement is mostly based on FactorVII, it's possible that a patient can have a "therapeutic PT" and still be hyper-coagulable initially.